Using PRP and Cord Blood in Treatment of Covid -19

Not Applicable

• Conditions: Virus
• Interventions: Combination Product: stem cells

• Registration Number: NCT04393415
• Lead Sponsor: Aljazeera Hospital

Brief Summary

covid - 19 is a critical viral infection that affects humans

Detailed Description

Covid -19 pandemic started was declared in 2020

Study Timeline

• Study First Submitted: 2020-05-15
• Study First Submitted QC: 2020-05-15
• Study First Posted: 2020-05-19
• Study Start: 2020-05-25
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-24
• Last Update Posted: 2020-07-27
• Primary Completion: 2020-08-25
• Study Completion: 2020-09-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion Criteria

• patients with negative test for covid -19

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
patients receiving LGF	stem cells	-
patients receiving Platelet rich plasma	stem cells	-

Primary Outcome Measures

Name	Time	Method
the number of patients with positive covid 19 who will improve after receiving stem cells	2 weeks	patients with positive covid 19 who will improve after receiving stem cells

Trial Locations

Locations (1)

Aljazeera( Al Gazeera) hospital; 🇪🇬 Giza, Egypt